Children between the ages of 5 and 11 could soon be eligible for a COVID-19 Booster Dose.
Pfizer and Bio-n-Tech plan to apply for emergency use authorization after releasing study results showing that a third dose of the vaccine in that age group shows a “high immune response.”
Nancy Soto has more information about the findings and about the clearance.
Watch the video for the full report.
–
–
